RASSF2A promoter methylation in hepatitis B virus-related hepatocellular carcinogenesis and its correlation with elevated serum α-fetoprotein level

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 29, Issue 3, 2009, Pages 309-312

  Ren, Jinghua ^a   He, Wenshan ^a   Zhang, Ruiguang ^a   Li, Zhenyu ^a   Cao, Wenmiao ^a   Yao, Jie ^a   Zhu, Fang ^a   Zhang, Tao ^a   Wu, Gang ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Epigenetic inactivation; Hepatocellular carcinoma; RASSF2A

Indexed keywords

ALPHA FETOPROTEIN; RASSF2 PROTEIN, HUMAN; TUMOR SUPPRESSOR PROTEIN;

ADULT; AGED; ARTICLE; BLOOD; DNA METHYLATION; FEMALE; GENETICS; HEPATITIS B; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; MALE; METABOLISM; MIDDLE AGED; PROMOTER REGION; VIROLOGY; COMPLICATION; YOUNG ADULT;

ADULT; AGED; ALPHA-FETOPROTEINS; CARCINOMA, HEPATOCELLULAR; DNA METHYLATION; FEMALE; HEPATITIS B; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROMOTER REGIONS, GENETIC; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 70349673155     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-009-0309-8     Document Type: Article

References (15)

1. H.B. El-Serag K.L. Rudolph 2007 Hepatocellular carcinoma: epidemiology and molecular carcinogenesis Gastroen-terology 132 7 2557 2576
2. J. Yao W. Yu Y. Chang, et al. 2008 Targeted screening of siRNA directed HBV polymerase gene for effective inhibition of HBV expression Huazhong Univ Sci Technolog Med Sci 28 3 266 271
3. L.S. Hsu H.C. Lee G.Y. Chau, et al. 2006 Aberrant methylation of EDNRB and p16 genes in hepatocellular carcinoma (HCC) in Taiwan Oncol Rep 15 2 507 511
4. M.D. Vos C.A. Ellis C. Elam, et al. 2003 RASSF2 is a novel K-Ras-specific effector and potential tumor suppressor J Biol Chem 278 30 28045 28051
5. M. Endoh G. Tamura T. Honda, et al. 2005 RASSF2, a potential tumor suppressor, is silenced by CpG island hypermethylation in gastric cancer Br J Cancer 93 12 1395 1399
6. W.N. Cooper R.E. Dickinson A. Dallol, et al. 2008 Epigenetic regulation of the ras effector/tumor suppressor RASSF2 in breast and lung cancer Oncogene 27 12 1805 1811
7. Z. Zhang D. Sun N. do Van, et al. 2007 Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma Int J Cancer 120 1 32 38
8. T. Imai M. Toyota H. Suzuki, et al. 2008 Epigenetic inactivation of RASSF2 in oral squamous cell carcinoma Cancer Sci 99 5 958 966
9. T.L. Lee W.K. Leung M.W. Chan, et al. 2002 Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma Clin Cancer Res 8 6 1761 1766
10. A. Hatzaki E. Razi K. Anagnostopoulou, et al. 2001 A modified mutagenic PCR-RFLP method for K-ras codon 12 and 13 mutations detection in NSCLC patients Mol Cell Probes 15 5 243 247
11. J.H. Ren J.S. Lin W.S. He, et al. 2006 RASSF2 induces activated Ras-dependent cell growth inhibition and apoptosis in human pancreatic cancer cells J Cancer Mol 2 3 117 122
12. L.B. Hesson R. Wilson D. Morton, et al. 2005 CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations Oncogene 24 24 3987 3994
13. H.W. Park H.C. Kang I.J. Kim, et al. 2007 Correlation between hypermethylation of the RASSF2A promoter and K-ras/BRAF mutations in microsatellite-stable colorectal cancers Int J Cancer 120 1 7 12
14. K. Harada S. Hiraoka J. Kato, et al. 2007 Genetic and epigenetic alterations of Ras signalling pathway in colorectal neoplasia: analysis based on tumour clinicopathological features Br J Cancer 97 10 1425 1431
15. S.Y. Peng W.J. Chen P.L. Lai, et al. 2004 High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations Int J Cancer 112 1 44 50